Covenant Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,985
Closed -$231K 165
2025
Q2
$231K Buy
4,985
+33
+0.7% +$1.62K 0.05% 146
2025
Q1
$302K Buy
4,952
+28
+0.6% +$1.63K 0.08% 137
2024
Q4
$279K Buy
+4,924
New +$275K 0.06% 151
2024
Q2
Sell
-3,857
Closed -$209K 164
2024
Q1
$209K Sell
3,857
-12,985
-77% -$661K 0.05% 141
2023
Q4
$864K Sell
16,842
-7,641
-31% -$401K 0.24% 92
2023
Q3
$1.42M Buy
24,483
+113
+0.5% +$6.92K 0.44% 69
2023
Q2
$1.56M Sell
24,370
-220
-0.9% -$14.8K 0.46% 73
2023
Q1
$1.7M Sell
24,590
-5,192
-17% -$366K 0.56% 76
2022
Q4
$2.14M Buy
29,782
+4,122
+16% +$311K 0.77% 61
2022
Q3
$1.82M Buy
25,660
+555
+2% +$40.3K 0.73% 62
2022
Q2
$1.93M Buy
25,105
+47
+0.2% +$3.58K 0.74% 57
2022
Q1
$1.83M Buy
25,058
+19
+0.1% +$1.28K 0.55% 61
2021
Q4
$1.56M Sell
25,039
-340
-1% -$19.9K 0.42% 59
2021
Q3
$1.5M Buy
25,379
+60
+0.2% +$3.95K 0.45% 62
2021
Q2
$1.69M Buy
25,319
+625
+3% +$40.8K 0.51% 55
2021
Q1
$1.56M Buy
24,694
+234
+1% +$14.6K 0.52% 61
2020
Q4
$1.52M Sell
24,460
-213
-0.9% -$13.1K 0.53% 57
2020
Q3
$1.49M Buy
24,673
+22
+0.1% +$1.32K 0.59% 56
2020
Q2
$1.45M Buy
24,651
+972
+4% +$58.1K 0.62% 61
2020
Q1
$1.32M Buy
23,679
+1,496
+7% +$91.4K 0.74% 59
2019
Q4
$1.42M Buy
22,183
+8
+0% +$458 0.69% 60
2019
Q3
$1.12M Buy
22,175
+2,969
+15% +$140K 0.6% 61
2019
Q2
$871K Buy
19,206
+800
+4% +$37.3K 0.46% 67
2019
Q1
$878K Buy
18,406
+1,830
+11% +$91.2K 0.48% 68
2018
Q4
$1.03M Hold
16,576
0.52% 64
2018
Q3
$1.03M Buy
16,576
+400
+2% +$23.7K 0.52% 64
2018
Q2
$895K Buy
16,176
+1,108
+7% +$59.8K 0.49% 68
2018
Q1
$953K Buy
15,068
+1,439
+11% +$92.6K 0.56% 62
2017
Q4
$835K Buy
13,629
+1,579
+13% +$98.8K 0.49% 72
2017
Q3
$768K Hold
12,050
0.47% 75
2017
Q2
$671K Sell
12,050
-420
-3% -$22.9K 0.43% 84
2017
Q1
$678K Sell
12,470
-7,570
-38% -$415K 0.46% 79
2016
Q4
$1.17M Buy
+20,040
New +$1.1M 0.79% 46

Other funds holding BMY